Page 112 - தலை ஆஃப் பெருநிறுவன தகவல்தொடர்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Seelos Therapeutics Raises $10 Million In Private Placement of Senior Secured Convertible Note Seelos Therapeutics, Inc. a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced the sale of a $12.0 million senior secured convertible note and shares of Seelos common stock to investors including Lind Global Asset Management II, LLC, an investment fund managed by The Lind Partners, a New York based institutional … – Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced the sale of a $12.0 million senior secured convertible note (the “Note”) and shares of Seelos common stock (the “Closing Shares”) to investors (the “Investors”), including Lind Global Asset Management II, LLC, an investment fund managed by The Lind Partners, a New Yo

New yorkUnited statesUnited kingdomRaj mehraPhillip valliereAnthony marcianoExchange commissionSeelos therapeutics incHead of corporate communicationsLind global asset managementSeelos therapeuticsLind partnersManaging directorClosing sharesSecurities actPrivate securities litigation reform act